As of 2025-07-03, the Relative Valuation of Cymabay Therapeutics Inc (CBAY) is (17.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.48 USD, the upside of Cymabay Therapeutics Inc based on Relative Valuation is -154.6%.
The range of the Relative Valuation is (17.70) - (16.91) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 18.4x | 18.1x |
| Forward P/E multiples | 19.3x - 22.3x | 20.5x |
| Fair Price | (17.70) - (16.91) | (17.74) |
| Upside | -154.5% - -152.1% | -154.6% |
| Date | P/E |